Search
Lumbar Fusion: Strategies to Lower Complications and Optimize Corrections
Focusing particularly on the needs of obese patients, neurosurgeon Aaron Clark, MD, PhD, discusses anterior and lateral approaches to lumbar interbody fusion.Enhancing MRI with AI to Improve Diagnosis of Brain Disorders
At the intersection of AI and medical science, there is growing interest in using machine learning to enhance imaging data captured by magnetic resonance imaging (MRI) technology.Managing PCOS with a Comprehensive Care Plan
Heather Gibson Huddleston, MD, details the comprehensive care plan for polycystic ovary syndrome (PCOS) used at the UCSF Center for Reproductive Health.Uterine Fibroids Conclusions
Dr. Jeannette Lager concludes her presentation on uterine fibroids by recapping the types and classifications, common presentations and medical treatment options.Care of Geriatric Patients in the Time of COVID-19
UCSF geriatrician and pulmonologist Leah Witt, MD, discusses how to identify high-risk senior patients, the most common course of the disease, useful monitoring methods and important follow-up on hospitalized patients after discharge.A Guide to GERD: Managing Symptoms and Complications of a Common Condition
With gastroesophageal reflux disease affecting 40% of the U.S. population every month, primary care providers need a straightforward plan for initiating therapy, as well as an up-to-date understanding of causes and treatment complications.Pediatric Spondylolisthesis: Identifying Surgical Candidates and Selecting the Approach
In a talk with relevance for both adult and pediatric spinal care providers, orthopedic surgeon Sigurd Berven, MD, discusses complex decisions on whether and how to treat a child with high-grade spondylolisthesis.Complex Spine Surgery: Secrets of Successful Closure
Dr. Scott Hansen discusses techniques, options and strategies to stabilize soft tissues and prevent post-op wound complications, even in the most challenging cases.UCSF Surgical Oncologists Providing New Treatment Options for Patients with Metastatic Gastrointestinal Cancers
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.Screening for Cervical Cancer: New Evidence on Options and Outcomes
Gynecologic oncologist Megan Swanson, MD, MPH, deciphers recent changes to cervical cancer screening guidelines and uses the data to illuminate the relative value of test options – Pap smears, detection of high-risk HPV strains, or both tests together.Deep Brain Stimulation for Medication-Resistant Dystonia: A UCSF Case Study
A 10-year-old boy developed left-foot inversion, which made it difficult for him to walk. He subsequently developed a tremor in his right arm, and then his neck and trunk began to twist. He was seen by several practitioners but did not get a correct diagnosis. At age 17, he was referred to the UCSF Movement Disorders and Neuromodulation Center.Why Do Some Brain Regions Resist Alzheimer’s?
UCSF researchers create "Google Maps” for how tau moves in the brain of Alzheimer’s patients.Hypertrophic Cardiomyopathy: What's All the HYPE?
Theodore Abraham, MD, discusses hypertrophic cardiomyopathy (HCM) a genetic heart disease in which the myocardium becomes abnormally thick.UCSF Internal Medicine Specialist Celebrated for Diabetes Epidemiology Research
Alka M. Kanaya, MD, UC San Francisco primary care physician and researcher, has been honored with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).UCSF Offers Growing Options for Focal Therapy in Prostate Cancer
In its commitment to tailoring prostate cancer treatment to the needs of each patient, UC San Francisco’s Department of Urology uses focal therapy as an important option for men with clinically significant cancers that are located in one region of the prostate.Evaluation & Common Presentation of Fibroids
Dr. Jeannette Lager examines the presentation of fibroids in ultrasound, MRI and CT imaging.Sorting Cancers by “Immune Archetypes” Represents Potential New Approach to Developing Precision Immunotherapies
Using data from over 300 patient tumors, UCSF researchers have described 12 classes of “immune archetypes” to classify cancer tumors. Their findings, published today in CELL, reveal that cancers from different parts of the body are immunologically similar to one another. These classifications provide unique strategies for enhancing each patient’s choice of cancer immunotherapies.Unconscious Bias in Patient Care: Harms and Paths to Healing
While physicians intend to treat all their patients with equal respect and compassion, studies show that favoritism and other implicit attitudes can emerge, especially in times of stress, affecting medical decisions and care quality.Burnout Interventions to Benefit Individuals and Systems
Sunita Mutha, MD, discusses common symptoms, the many negative consequences for the health care field, and proven interventions.Lung Transplant Outcomes at UCSF Among the Nation’s Best
For nine consecutive years, the UCSan FranciscoLung Transplant Program has achieved significantly higher-than-expected survival rates following transplant surgery. It is the only lung transplant program in the country with this record.Cervical and Thoracolumbar Spinal Deformity Treatment Strategies, Part III: Case Examples
Lee Tan, MD discusses three recent cervical spine and thoracolumbar spinal deformity cases and the surgical interventions used to treat these diverse conditions.Optimize Spinal Surgery Outcomes Through Teamwork
Vascular surgeon Dr. Charles Eichler discusses UCSF’s success with including vascular surgeons in lumbar fusion procedures and finding the least invasive approach for each patient.Minimally-Invasive Mitral Valve Surgery
Tobias Deuse, MD, discusses the advantages of minimally invasive approaches for the treatment of mitral valve insufficiency.This New Treatment Can Adjust to Parkinson's Symptoms in Real Time
People with Parkinson’s disease have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.